CSIMarket
 


Schrodinger Inc   (SDGR)
Other Ticker:  
 
 

SDGR's Revenue Growth by Quarter and Year

Schrodinger Inc 's Revenue results by quarter and year




SDGR Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 74.08 56.84 46.17 33.03
III Quarter September 41.64 36.98 29.85 25.80
II Quarter June 35.19 38.47 29.78 23.09
I Quarter March 64.78 48.66 32.13 26.17
FY   215.69 180.95 137.93 108.09



SDGR Revenue fourth quarter 2023 Y/Y Growth Comment
Schrodinger Inc achieved in the fourth quarter 2023, above Company average Revenue growth of 30.33% year on year, to $ 74.08 millions.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 36 other companies have achieved higher Revenue growth. While Schrodinger Inc ' s Revenue rise of 30.33% ranks overall at the positon no. 262 in the fourth quarter 2023.




SDGR Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 30.33 % 23.11 % 39.78 % -
III Quarter September 12.6 % 23.89 % 15.7 % -
II Quarter June -8.53 % 29.18 % 28.97 % -
I Quarter March 33.13 % 51.45 % 22.77 % -
FY   19.2 % 31.19 % 27.61 % -

Financial Statements
Schrodinger Inc 's fourth quarter 2023 Revenue $ 74.08 millions SDGR's Income Statement
Schrodinger Inc 's fourth quarter 2022 Revenue $ 56.84 millions Quarterly SDGR's Income Statement
New: More SDGR's historic Revenue Growth >>


SDGR Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 77.91 % 53.7 % 54.67 % 28.02 %
III Quarter September 18.33 % -3.87 % 0.24 % 11.74 %
II Quarter June -45.68 % -20.94 % -7.31 % -11.77 %
I Quarter March 13.97 % 5.39 % -2.72 % -
FY (Year on Year)   19.2 % 31.19 % 27.61 % -




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #37
Healthcare Sector #62
Overall #262

Revenue Y/Y Growth Statistics
High Average Low
51.47 % 25.2 % -8.53 %
(Mar 31 2022)   (Jun 30 2023)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #37
Healthcare Sector #62
Overall #262
Revenue Y/Y Growth Statistics
High Average Low
51.47 % 25.2 % -8.53 %
(Mar 31 2022)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Schrodinger Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
77.91 % 11.44 % -45.68 %
(Dec 31 2023)  


SDGR's IV. Quarter Q/Q Revenue Comment
Schrodinger Inc achieved in the IV. Quarter 2023 above company average sequential Revenue jump of 77.91%, to $ 74.08 millions, from $41.64 millions in the third quarter.
Schrodinger Inc is impressively improving, not just recording above regular growth, and also accelerating speed.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Schrodinger Inc 's Revenue growth quarter on quarter, overall rank is 71.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #14
Overall #71
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #14
Overall #71
Revenue Q/Q Growth Statistics
High Average Low
77.91 % 11.44 % -45.68 %
(Dec 31 2023)  


SDGR's IV. Quarter Q/Q Revenue Comment
Schrodinger Inc achieved in the IV. Quarter 2023 above company average sequential Revenue jump of 77.91%, to $ 74.08 millions, from $41.64 millions in the third quarter.
Major Pharmaceutical Preparations company is going from strength to strength, with claiming above average gain, but also increasing rate, Jordan O. Hernandez, a business veteran added.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Schrodinger Inc 's Revenue growth quarter on quarter, overall rank is 71.


Schrodinger Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 215.69 $ 198.45 $ 193.79 $ 197.07 $ 180.96
Y / Y Revenue Growth (TTM) 19.2 % 16.54 % 18.78 % 27.58 % 31.19 %
Year on Year Revenue Growth Overall Ranking # 171 # 59 # 123 # 609 # 630
Seqeuential Revenue Change (TTM) 8.69 % 2.4 % -1.66 % 8.91 % 6.27 %
Seq. Revenue Growth (TTM) Overall Ranking # 786 # 495 # 578 # 1464 # 1420




Cumulative Revenue growth Comment
Although Schrodinger Inc 's Annual Revenue growth year on year were below company's average 27.55% , Revenue announced in the Dec 31 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 19.2% year on year, from 16.54% in Sep 30 2023.

In the Healthcare sector 38 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 59 to 171.

Revenue TTM Q/Q Growth Statistics
High Average Low
36.45 %
27.55 %
16.54 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 36
Healthcare Sector # 39
Overall # 171

Revenue TTM Y/Y Growth Statistics
High Average Low
36.45 %
27.55 %
16.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 36
Sector # 115
S&P 500 # 786
Cumulative Revenue growth Comment
Although Schrodinger Inc 's Annual Revenue growth year on year were below company's average 27.55% , Revenue announced in the Dec 31 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 19.2% year on year, from 16.54% in Sep 30 2023.

In the Healthcare sector 38 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 59 to 171.

Revenue TTM Q/Q Growth Statistics
High Average Low
36.45 %
27.55 %
16.54 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 36
Healthcare Sector # 39
Overall # 171

Revenue TTM Y/Y Growth Statistics
High Average Low
36.45 %
27.55 %
16.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 36
Sector # 115
S&P 500 # 786




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SDGR's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SDGR's Competitors
Revenue Growth for Schrodinger Inc 's Suppliers
Revenue Growth for SDGR's Customers

You may also want to know
SDGR's Annual Growth Rates SDGR's Profitability Ratios SDGR's Asset Turnover Ratio SDGR's Dividend Growth
SDGR's Roe SDGR's Valuation Ratios SDGR's Financial Strength Ratios SDGR's Dividend Payout Ratio
SDGR's Roa SDGR's Inventory Turnover Ratio SDGR's Growth Rates SDGR's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Theralink Technologies Inc 51.82%$ 51.820 millions
Intra cellular Therapies Inc 50.34%$ 50.336 millions
Adma Biologics Inc 49.43%$ 49.427 millions
Insmed Inc48.27%$ 48.273 millions
Hims and Hers Health Inc 48.15%$ 48.151 millions
Armata Pharmaceuticals Inc 45.39%$ 45.385 millions
G1 Therapeutics Inc 45.10%$ 45.102 millions
Natera inc 43.20%$ 43.200 millions
Shockwave Medical Inc 41.36%$ 41.361 millions
Revance Therapeutics Inc 39.82%$ 39.819 millions
Evolus Inc 39.76%$ 39.759 millions
Ani Pharmaceuticals Inc39.71%$ 39.713 millions
Inspire Medical Systems inc 39.46%$ 39.459 millions
Insulet Corporation37.90%$ 37.896 millions
Foghorn Therapeutics Inc 37.88%$ 37.882 millions
Viemed Healthcare Inc 35.28%$ 35.275 millions
Kiniksa Pharmaceuticals ltd 34.76%$ 34.760 millions
Lantheus Holdings Inc 34.56%$ 34.557 millions
Xeris Biopharma Holdings Inc 33.93%$ 33.931 millions
Deciphera Pharmaceuticals Inc 32.88%$ 32.877 millions
Urogen Pharma Ltd 32.54%$ 32.539 millions
Anaptysbio Inc 32.27%$ 32.271 millions
Twist Bioscience Corporation31.81%$ 31.811 millions
Clearpoint Neuro Inc 31.62%$ 31.620 millions
Amicus Therapeutics inc 31.47%$ 31.466 millions
Corcept Therapeutics Inc31.39%$ 31.390 millions
Harmony Biosciences Holdings inc 31.30%$ 31.303 millions
Alnylam Pharmaceuticals Inc 31.25%$ 31.245 millions
Tarsus Pharmaceuticals Inc 30.76%$ 30.760 millions
Biofrontera Inc 30.41%$ 30.414 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com